ReShape Lifesciences, Inc. (RSLS) Financials
RSLS Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 7.8 million | 4.7 million |
2023-06-30 | 11.9 million | 5.1 million |
2023-03-31 | 11.1 million | 7.5 million |
2022-12-31 | 11.1 million | 7.5 million |
RSLS Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -2.8 million | 216000 |
2023-06-30 | -6.7 million | 218000 |
2023-03-31 | -2.9 million | 130000 |
2022-12-31 | -2.9 million | 130000 |
RSLS Net Income
No data available :(
RSLS Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 1.4 million | - | 285000 |
2023-06-30 | 4.6 million | - | 307000 |
2023-03-31 | 3.9 million | - | 86000 |
2022-12-31 | - | - | 171000 |
RSLS Shares Outstanding
RSLS Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 542000 | 2.1 million | 1.8 million |
2023-06-30 | 36000 | 581000 | 2.4 million | 2.2 million |
2023-03-31 | 79000 | 441000 | 3.8 million | 2.1 million |
2022-12-31 | 79000 | 441000 | 5.9 million | - |
RSLS Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 2.2 million | 867000 |
2023-06-30 | 2.3 million | 1.1 million |
2023-03-31 | 3.1 million | 1.5 million |
2022-12-31 | 3.1 million | 1.5 million |
RSLS
Price: $0.17
52 week price:
Earnings Per Share: -38.56 USD
P/E Ratio: -0.01
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Volume: 32400
Market Capitalization: 3.9 million